Clinical outcomes after injection of a compounded pharmaceutical for prophylaxis after cataract surgery: a large-scale review.

about

Ex vivo rabbit cornea diffusion studies with a soluble insert of moxifloxacin.

P2860

Q50036998-10071A70-94F4-4063-AE60-3CF75022D43A

P2860

Clinical outcomes after injection of a compounded pharmaceutical for prophylaxis after cataract surgery: a large-scale review.

Item

http://www.wikidata.org/entity/Q38960792

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Clinical outcomes after inject ...... surgery: a large-scale review.

@en

type

Item

label

Clinical outcomes after inject ...... surgery: a large-scale review.

@en

prefLabel

Clinical outcomes after inject ...... surgery: a large-scale review.

@en

P1476

Clinical outcomes after inject ...... surgery: a large-scale review.

@en

P2093

Janika S Roman

http://www.w3.org/2001/XMLSchema#string

Julia A Haller

http://www.w3.org/2001/XMLSchema#string

Lisa A Hark

http://www.w3.org/2001/XMLSchema#string

Robert Bailey

http://www.w3.org/2001/XMLSchema#string

Sydney L Tyson

http://www.w3.org/2001/XMLSchema#string

Tingting Zhan

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International

P2860

Prophylaxis of postoperative endophthalmitis following cataract surgery: results of the ESCRS multicenter study and identification of risk factors

Difluprednate ophthalmic emulsion 0.05% (Durezol) administered two times daily for managing ocular inflammation and pain following cataract surgery

Endophthalmitis: state of the art.

Postoperative Hemorrhagic Occlusive Retinal Vasculitis: Expanding the Clinical Spectrum and Possible Association with Vancomycin.

Acute-onset endophthalmitis after cataract surgery (2000-2004): incidence, clinical settings, and visual acuity outcomes after treatment.

Effects of cycloplegia and iris pigmentation on postoperative intraocular inflammation.

Evaluation of costs for cystoid macular edema among patients after cataract surgery.

Incidence of visually significant pseudophakic macular edema after uneventful phacoemulsification in patients treated with nepafenac.

Safety of intracameral moxifloxacin for prophylaxis of endophthalmitis after cataract surgery.

Intracameral dexamethasone reduces inflammation on the first postoperative day after cataract surgery in eyes with and without glaucoma.

P304

73-80

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.1097/ICU.0000000000000329

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P5008

ScienceSource

P577

2016-09-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

2017-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27653606

http://www.w3.org/2001/XMLSchema#string

P921

Chidenhi

endophthalmitis

infection

biomedical investigative technique

P932

5145248

http://www.w3.org/2001/XMLSchema#string

Clinical outcomes after injection of a compounded pharmaceutical for prophylaxis after cataract surgery: a large-scale review.

about

P2860

P2860

Clinical outcomes after injection of a compounded pharmaceutical for prophylaxis after cataract surgery: a large-scale review.

description

name

type

label

prefLabel

P1433

P1476

P2093

P275

P2860

P304

P31

P356

P433

P478

P5008

P577

P698

P921

P932

P356

P1433

P1476

P2093

P275

P2860

P304

P31

P356

P433

P478

P5008

P577

P698

P921

P932